Addus HomeCare stock has a USD 129.33 consensus target
Published on 10/15/2026 at 19:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and reporting date
- MarketBeat reported an average target of USD 129.33 from 11 analysts on October 13, 2026.
- Addus HomeCare's second-quarter revenue rose 8.00 percent to USD 377.41 million.
- Addus HomeCare stock costs EUR 104.50 at Lang & Schwarz on October 15, 2026 at 7:10 p.m. CEST, with a 0.46 percent Nasdaq move.
- Addus HomeCare will release third-quarter results on November 3, 2026, after the market close.
Addus HomeCare (ISIN US0067391062) has an average 12-month analyst target of USD 129.33, according to MarketBeat on October 13, 2026. The target stood 10.39 percent above the USD 117.16 Nasdaq price, based on the latest quote. At Lang & Schwarz, the stock was trading at EUR 104.50 on October 15, 2026 at 7:10 p.m. CEST, while the Nasdaq quotation was up 0.46 percent on the day.
Revenue growth sets the operating base
Addus reported second-quarter 2026 revenue of USD 377.41 million, an 8.00 percent increase from the year-earlier period, while adjusted earnings per share reached USD 1.73 against a USD 1.70 consensus estimate, Quartr reported. The period ended June 30, 2026. Operating cash flow was USD 40.01 million, giving the quarter a concrete cash-generation measure alongside the revenue increase.
Stock sits below its yearly high
The Nasdaq quotation had a 52-week range of USD 87.95 to USD 124.44 on October 15, 2026. At USD 117.16, Addus traded 5.85 percent below the high and 33.21 percent above the low. Volume was 71,330 shares against an average of 213,667, so the latest session's turnover was below that average.
Valuation meets a November date
Addus had a market capitalization of USD 2.2 billion and a trailing price-to-earnings ratio of 20.55 on October 15, 2026. The company is scheduled to release third-quarter results after the market close on November 3, 2026, followed by a conference call on November 4 at 9:00 a.m. Eastern Time, according to Business Wire. The next report will show whether the 8.00 percent second-quarter revenue growth carried into the September quarter.
Comparison with peers
Addus HomeCare (Nasdaq, USD): plus 0.46 percent, P/E 20.55, market capitalization USD 2.2 billion
The Ensign Group (Nasdaq, USD): plus 1.64 percent, P/E 28.02, market capitalization USD 10.4 billion
CareTrust REIT (Nasdaq, USD): plus 1.20 percent, P/E 22.82, market capitalization USD 8.7 billion
Price and upcoming results
Addus combines an 8.00 percent second-quarter revenue increase with a USD 129.33 average analyst target and a November 3 reporting date. The Nasdaq stock stood 5.85 percent below its 52-week high, while its 20.55 price-to-earnings ratio was below the comparable Ensign Group multiple of 28.02.
At Lang & Schwarz, Addus HomeCare stock was trading at EUR 104.50 on October 15, 2026 at 7:10 p.m. CEST. On Nasdaq, the stock was up 0.46 percent on the day.
The further course of trading is shown by the continuously updated real-time quote of Addus HomeCare stock.
Addus HomeCare stock facts
- Company: Addus HomeCare Corporation
- ISIN: US0067391062
- Ticker: ADUS
- Primary exchange: Nasdaq
- Price Lang & Schwarz (as of October 15, 2026, 7:10 p.m. CEST): EUR 104.50
- Nasdaq daily change: plus 0.46 percent
- Market capitalization: USD 2.2 billion (as of October 15, 2026)
- 52-week range: USD 87.95-124.44 (as of October 15, 2026)
- Sector / Industry: Healthcare / Medical - Care Facilities
- Next earnings date: November 3, 2026
Market context: Market report S&P 500.
